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ABSTRACT
Background. Undertreatment of depression in primary care is common. Eﬀorts to address this
tend to overlook the role of patient attitudes. Our aim was to validate and describe responses to
a questionnaire about attitudes to depression and its treatment in a sample with experience of
moderate and severe depressive episodes.
Method. Cross-sectional survey of 866 individuals with a conﬁrmed history of an ICD-10
depressive episode in the 12 months preceding interview, recruited from 7271 consecutive general
practitioner (GP) attendees in 36 general practices in England and Wales. Attitudes to and beliefs
about depression were assessed using a 19-item self-report questionnaire.
Results. Factor analysis resulted in a three-factor solution: factor 1, depression as a disabling,
permanent state; factor 2, depression as a medical condition responsive to support ; and factor 3,
antidepressants are addictive and ineﬀective. Participants who received and adhered to anti-
depressant medication and disclosed their depression to family and friends had signiﬁcantly lower
scores on factors 1 and 3 but higher scores on factor 2.
Conclusions. People with moderate or severe depressive episodes have subtle and divergent views
about this condition, its outcome, and appropriate help. Such beliefs should be considered in
primary care as they may signiﬁcantly impact on help seeking and adherence to treatment.
INTRODUCTION
Depression has a community prevalence of
about 10% (Singleton et al. 2001; Layard, 2006)
and is expected to become the second highest
cause of disease burden worldwide by 2020
(Murray & Lopez, 1997). The annual cost of
depression in England alone was estimated at £9
billion in 2000, of which 90% was attributed to
around 110 million lost working days (Thomas
& Morris, 2003). This ﬁgure has been estimated
at £17 billion per annum for the UK as a whole,
equivalent to 1.5% of the gross domestic
product (GDP) (Layard, 2006). The prevalence
of depression in developed countries has not
fallen in recent decades, despite eﬀective treat-
ments, evidence-based guidelines (NICE, 2004)
and public education campaigns (Brugha, 1995;
Kendrick, 2000; Department of Health, 2001).
The unmet need for treatment becomes even
more alarming when considering only cases of
severe disorder (Demyttenaere et al. 2004). Only
a minority of those suﬀering from clinically sig-
niﬁcant episodes of disorder receive and adhere
to treatments in keeping with evidence-based
guidelines (Scott, 2006). Population-based sur-
veys in the UK, the USA and Canada found
that around one-half of those with a recent or
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current depressive episode of at least moderate
severity had sought medical care for this
(Bebbington et al. 2000), with up to 62% re-
porting medical consultation for this problem at
some time in the preceding year (Singleton et al.
2001; Brugha et al. 2004; Wang et al. 2005).
Previous studies report that 30–40% of those
in the community who are depressed receive
medical treatment (medication or psychological
treatments) (Lin & Parikh, 1999; Singleton et al.
2001). This ﬁgure fell to less than 25% when
only treatments of ‘minimal ’ adequacy or better
were included in the US National Comorbidity
Study replication (NCS-R) (Young et al. 2001).
The latter study also found that only 15%
of those with major depressive disorder seen
in general medical settings (including primary
care) in the past year received treatment meeting
these criteria. Recent ﬁndings indicate increases
in rates of medical help seeking and anti-
depressant prescribing (from around 5% to
16%) during the 1990s, but not in the use
of psychological therapies. Nor was there any
signiﬁcant reduction in the prevalence of de-
pression over the same period (Brugha et al.
2004). The quadrupling of antidepressant pre-
scribing in this period includes a 12-fold rise in
the rate of prescriptions among those free from
psychiatric symptoms at the time of interview.
The reasons for these high levels of under-
treatment remain unclear, and are likely to be
complex. Undertreatment includes failing to
seek help, declining care and dropping out of
care (Edlund et al. 2002; Anderson et al. 2006).
Many years of attempting to improve phys-
icians’ performance, including the development
and dissemination of guidelines (Kendrick,
2000; Thompson et al. 2000; NICE, 2004), have
produced only modest results. More recently,
interest has turned to the eﬀects of patients’
attitudes to depression and preferences for
treatment (Nutting et al. 2002; Jorm et al. 2004;
Kessing et al. 2005; Lin et al. 2005; Pyne et al.
2005). Intriguingly, while two recent trials have
shown that the eﬃcacy and cost-eﬀectiveness of
treatments for depression are greatly enhanced
by individuals’ preferences for the treatments
oﬀered (Rost et al. 2001; Lin et al. 2005; Pyne
et al. 2005), a systematic review of studies with
patient preference designs has found no such
eﬀect (King et al. 2005). However, this literature
is characterized by variability in the nature of
attitudes and beliefs studied, and the manner in
which these are elicited. Most studies have been
concerned primarily with adherence to anti-
depressant treatment (Kessing et al. 2005), and
few have explored attitudes about depression as
well as treatment preferences. It has been com-
mon to concentrate on receptiveness to treat-
ment in general (Cooper-Patrick et al. 1997;
Dwight-Johnson et al. 2000), or to psycho-
logical or pharmacological treatments (Kessing
et al. 2005) more speciﬁcally, usually as dichot-
omous outcomes (Rost et al. 2001; Pyne et al.
2005).
To understand the determinants of under-
treatment of depression in primary care, we
recruited a large sample of individuals with a
recent history of ICD-10 moderate or severe
depressive episodes. The aim of the present
paper was to validate and describe the responses
to a questionnaire about attitudes to depression
and its treatment. We hypothesized that (1)
those who viewed depression as treatable would
be more likely to have received and adhered
to evidence-based treatment for their recent
depressive episode; (2) those who were positive
about the merits of antidepressant medication
were more likely to have received and adhered
to evidence-based pharmacotherapy; and (3)
individuals who perceived depression as shame-
ful and stigmatizing were the least likely (a) to
have disclosed a recent episode to family or
friends, or (b) to have received and adhered to
evidence-based treatment.
METHOD
Design and setting
A cross-sectional survey was undertaken in
general practices in England and Wales belong-
ing to the UK General Practice Research
Framework (GPRF). The GPRF comprises
over 1200 general practices throughout the UK
involved in epidemiological, primary care and
health services research. Thirty-six general
practices took part in this study. These were re-
cruited from all regions on the basis of location,
socio-economic deprivation (Jarman score for
practice, banded as high, medium or low) and
practice size (single-handed, 2–3 principals and
o4 principals). We initially proposed to recruit
50 practices and issued a call for expressions of
interest within the GPRF. Approximately 60
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practices replied, from which 52 were invited
to take part and 46 sent a research nurse to one
of three training days. Of the 36 practices that
contributed to data collection, 13 were located
in Trent, Eastern and West Midlands regions,
nine in the North, Yorkshire and the North
West, seven in the South West, six in London
and the South East, and one in Wales. Although
the South West and West Midlands were over-
represented (56% v. 22% of all GPRF prac-
tices), and the South East under-represented
(14% v. 28% of GPRF practices), study prac-
tices approximated the distribution of GPRF
practices in terms of area type (e.g. 31% in cities
or industrial areas versus 31% for all GPRF
practices). Average list sizes were slightly higher
for study practices (9911 v. 7399 for all GPRF
practices), while deprivation scores tended to be
lower (e.g. average Jarman 91 score 5.7 v. 7.9 for
all GPRF practices).
Participants
Consecutive attendees aged 18–75 at partici-
pating general practices with an appointment to
see a doctor, nurse or other professional at the
practice about themselves were approached in
the waiting room. Exclusion criteria included
learning diﬃculties, cognitive impairment that
would prevent completion of the study assess-
ments, and inability to communicate in English.
Measures
Ascertainment of ICD-10 depressive episodes
in the preceding 12 months
Individuals who had experienced an ICD-10
depressive episode (index episode) in the 12
months prior to interview were identiﬁed using a
two-stage procedure. Research nurses from
participating practices were trained to adminis-
ter the study assessments.
Attendees were asked to complete a brief,
10-item waiting room screening questionnaire
containing items taken from the depression
section of the 12-month version of the Com-
posite International Diagnostic Interview (CIDI;
WHO, 1997). This brief pencil-and-paper ques-
tionnaire, which took no more than 5 minutes
to complete, was developed for this study.
Terminology was the same as that used in the
CIDI, with questions that enquired about
‘periods when you have felt sad, empty or de-
pressed in the past 12 months’. Replicating the
structure of the CIDI, two stem questions asked
respectively whether in the past 12 months the
respondent recalled 2 weeks or longer ‘when
nearly every day you have felt sad, empty, or
depressed for most of the day’ and ‘when you
lost interest in most things like work, hobbies
and other things you usually enjoyed’. Those
who answered ‘Yes ’ to either question were
asked to complete a further eight items con-
cerning ‘the time (or times) in the past 12
months when you felt sad, empty, or depressed
or when you lost interest in most things nearly
every day for 2 weeks or longer’. These items
(each with Yes/No format) used CIDI de-
pression items covering fatigue, appetite, weight
loss, insomnia, concentration, and feelings of
worthlessness, inferiority and guilt.
A pilot study compared responses to this
questionnaire (in a general practice waiting
room) against the 12-month version of the CIDI
depression section administered by telephone
approximately 1 week later. Although too small
for deﬁnitive statistical analysis, the results
suggested that an optimum balance between
sensitivity and speciﬁcity was likely to be
achieved using a cut-oﬀ of o5 (out of 10),
including at least one positive response to the
ﬁrst two (stem) questions. This cut-point was
also chosen to maximize the positive predictive
value in order to minimize costly ‘false positive’
second-stage interviews. Those scoring at or
above this level were invited by telephone (or
letter) to participate in a face-to-face interview
with a research nurse.
The occurrence of one or more depressive
episodes was established at face-to-face inter-
view with a researcher using the depression
section from the 12-month version of the CIDI
(WHO, 1997). Severity was rated at the time
that most symptoms were present concurrently
and diagnosis was established using the research
version of ICD-10 (WHO, 1993).
Treatments for depression interview
Sources and types of help sought, general
practitioner (GP) consultations, and receipt of
and adherence to medication and psychological
treatments were assessed using a structured
interview designed for this study. This was
administered during the second-stage interview
to all individuals found to have experienced an
ICD-10 depressive episode in the preceding 12
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months. Questions concerned the identity, dose
and duration of adherence to all treatments
received in respect of the index episode of de-
pression.
This interview was administered directly after
the depression section of the 12-month CIDI.
As many individuals with depression do not
endorse this term, the latter begins by eliciting
core symptoms of depression (low mood, loss of
interest and/or fatigue) and then referring to the
speciﬁc ‘problems’ endorsed rather using than
the word ‘depression’ when asking about other
symptoms. The period about which treatment
questions were asked was anchored during the
CIDI interview by identifying the month in
the preceding year when the respondent had the
‘ largest number of problems [symptoms] at
the same time’. Using CIDI terminology
(‘problems’ such as ‘ feeling sad, empty or
depressed, etc. ’ rather than ‘symptoms’ or ‘de-
pression’), participants were asked to identify
the month and the year when this depressive
episode began and ended.
Participants were reminded about the ‘prob-
lems’ they had described in the preceding year in
response to the CIDI questions and the month
when these were at their worst. They were then
asked if they had spoken with their GP about
these problems, and about the timing of the ﬁrst
consultation in respect of this episode.
All possible treatments were ﬁrst enumerated,
starting with medication. Participants were
asked if their GP or any other doctor had pre-
scribed any medicines since the time when they
had ﬁrst consulted their doctor about the index
episode of depression identiﬁed during the CIDI
interview. Using a show card containing the
names of all antidepressants listed in the British
National Formulary (BNF), participants were
asked to identify up to three drugs that they had
been prescribed. For each drug mentioned,
questions covered dose, duration of adherence,
and how often, on average, they had remem-
bered to take this medicine. Further questions
asked if they were still taking this drug, and if
not, why not and whether discontinuation had
been discussed with a doctor.
Participants were asked about psychological
and other treatments. They were reminded of
the month when they reported that the index
episode had begun, and were asked if they had
been referred to (whether by someone else or by
self-referral) a counsellor within the practice, a
counsellor outside of the practice, psychiatrist,
psychologist, psychotherapist or psychoanalyst,
or other mental health professional. Taking
each in turn (where endorsed), participants were
asked how many sessions they had attended,
whether they were still attending and the
reasons (where appropriate) for termination.
Finally, this interview asked about disclosure
of depression. Participants were asked ‘Since
[month when the index episode began], have you
told any of your family or friends that you [were
feeling sad, empty or depressed/had lost interest
in most things/lacked energy]? ’
Criteria for evidence-based treatments
Treatments were divided into pharmacological
and psychological, and criteria for appropriate-
ness were derived from current evidence-based
guidelines. We followed previous studies in
operationalizing dose, duration and adherence,
and setting thresholds that were consistent
with minimally adequate treatment (Wang et al.
2005). Pharmacological treatment was said
to have met evidence-based standards when a
participant reported having taken (i) a thera-
peutic dose of an antidepressant, (ii) for at
least 4 weeks, (iii) at a minimum frequency
of o4 days per week on average. Therapeutic
doses of antidepressant were based on the BNF.
This was taken as o75 mg/day of dothiepin
or amitryptiline, o20 mg/day of ﬂuoxetine or
paroxetine, o75 mg/day of venlafaxine and
>50 mg/day of sertraline. Psychological treat-
ment was considered to have met evidence-
based standards when a participant reported
referral to a counsellor, psychologist or psy-
chotherapist, and either (i) they attended o3
sessions, or (ii) the treatment had been com-
pleted, or (iii) they were still attending.
Attitudes to depression and its treatment
(ADepT questionnaire)
Participants completed a new 19-item self-
report questionnaire concerning attitudes to
depression (13 items) and its treatment (six
items). Several items were based on those found
in existing measures at the time that our study
began (Botega et al. 1992; Priest et al. 1996).
Items were selected to address common mis-
conceptions about depression (‘You must be
careful not to upset someone who has been
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depressed, or they will get ill again’), and the
sense of stigma and shame that often ac-
company this condition (‘If other people knew
I had been depressed, they would think less
of me’) as well as views about treatment
(‘Counselling is an eﬀective way of treating
depression’). All items were rated using a
ﬁve-point scale with responses ranging from
‘strongly agree ’ (5) to ‘strongly disagree ’ (1).
Positive and negative phrasing was used to
prevent response set bias, and we included two
items that asked about possible advantages
of depression (e.g. ‘People with depression are
more creative and imaginative than others’).
Questionnaire items are shown in Table 2.
Socio-economic status. This was assessed using
questions about employment status, housing
tenure, car access, education and ﬁnancial
strain. The latter was assessed using a question
commonly used in social surveys, the response
to which is highly predictive of current and
future rates of psychiatric morbidity (Weich &
Lewis, 1998).
Analysis
Cronbach’s a was calculated to assess the
internal reliability of the ADepT questionnaire.
We used principal factor analysis to investigate
and describe the underlying factor structure of
the questionnaire. The number of factors was
determined by examination of a scree plot and
the size of the eigenvalues (Cattell, 1966). After
factor extraction, an orthogonal (varimax)
rotation was made to achieve a simpler factor
structure. When analysing factor loadings, we
chose 0.4 as a cut-oﬀ for size of loading to be
interpreted. The greater the factor loading, the
more the item is a pure measure of the factor.
Principal factor analysis was repeated after
stratifying by severity of depressive episode,
to see whether this aﬀected underlying item
response patterns.
Regression-based factor scores were derived
from the rotated components, and were nor-
malized to have a mean of 0 and standard
deviation of 1. All analyses were undertaken
using Stata 8 (StataCorp, 2004). To reﬂect the
clustered nature of the sample, analyses were
undertaken using survey commands that adjust
standard errors and x2 statistics for clustering
(autocorrelation) within clinics. Diﬀerences in
mean factor scores between those who did
and did not receive evidence-based treatments,
and those who did and did not disclose their
depression to family or friends, were estimated
using linear (least squares) regression.
RESULTS
Excluding those who were ineligible, 7718
individuals were asked to take part in screening
and 7271 (94.2%) completed the waiting room
questionnaire. Of those who completed the
questionnaire, 2211 (30.4%) scored above the
inclusion threshold for interview. A total of
975 individuals (44.1% of those with positive
screen results) took part in the second stage
interview. No statistically signiﬁcant diﬀerence
was found in screening score between those
who took part in the interview and those who
declined or were not available [mean diﬀerence
x0.04, 95% conﬁdence interval (CI) x0.18 to
0.11, p=0.61].
At interview, 866 individuals (88.8% of those
interviewed) were found to have experienced an
ICD-10 depressive episode in the preceding 12
months, of whom 812 (94.2%) endorsed all
three ‘core ’ depressive symptoms. Twelve indi-
viduals (1.4%) had experienced a mild depres-
sive episode, 175 (20.3%) a moderate episode,
and 679 (78.4%) a severe depressive episode. Of
those with a conﬁrmed depressive episode, 786
(90.8%) completed the ADepT questionnaire in
full, and analyses were based on this group. The
characteristics of the study sample are shown in
Table 1.
In total, 330 individuals with ICD-10 depres-
sive episodes (38.1% of the sample) reported
receipt of and adherence to evidence-based
treatment. Two hundred and sixty-seven (30.8%
of the sample) met minimum criteria for
evidence-based antidepressant treatment. Only
99 individuals (11.5% of the sample) met mini-
mum criteria for evidence-based psychological
treatment.
Cronbach’s a was 0.73 for the full scale.
Principal factor analysis resulted in nine factors
with eigenvalues greater than 0. Inspection of
the scree plot (Fig. 1) was consistent with a
three-factor solution, although three-, four- and
ﬁve-factor models were all considered before the
former was judged the most parsimonious.
Interpretation was not made any clearer, even
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after rotation, by the inclusion of more than
three factors.
Factor loadings after rotation are shown in
Table 2. Eight items had high positive loadings
on the ﬁrst factor, and reﬂected concerns about
the emotional instability of people with de-
pression, the shamefulness of the condition and
the poor prognosis. We entitled this factor
‘depression as permanent, disabling and stigma-
tizing ’. Three items were highly and positively
loaded on the second factor. These items en-
compass a more sympathetic and understanding
attitude to depression, which is seen as a medical
condition that can aﬀect anyone. We have called
this ‘depression is a medical condition that re-
sponds to support ’. Two items had high loadings
(one of which had a negative sign) on the
third factor. These items were concerned with
antidepressants. The positive loaded item was
‘antidepressants are addictive ’, while the nega-
tively loaded item was ‘antidepressants are an
eﬀective way of treating depression’. We have
therefore called this factor ‘antidepressants are
addictive and ineﬀective ’.
These results were largely unchanged when
the sample was stratiﬁed by severity of depress-
ive episode as in Table 1. The results for the
severe depression group were almost identical to
those in the sample as a whole. The results were
slightly diﬀerent in the mild and moderate
depressive episode group. Although the same
three-factor solution pertained, factor loadings
were subtly diﬀerent. On factor 1, item 6 ‘If you
have depression, you should be able pull to
yourself together ’ (factor loading 0.41) replaced
item 17 ‘When I have been depressed in the
past, I have kept it a secret ’ (0.48). On factor 2,
loadings on items 9 ‘Depression is a medical
condition, just like any other illness ’ and 18
‘Anybody can suﬀer from depression’ were re-
duced very slightly, to just below 0.40. Loadings
on factor 3 were unchanged.
Tests of study hypotheses
Those who reported receiving and adhering to
evidence-based antidepressant medication for
the index episode had signiﬁcantly lower scores
on factor 1 (depression as permanent, disabling
and stigmatizing) and factor 3 (antidepressants
are addictive and ineﬀective) and higher scores
on factor 2 (depression is a medical condition
that responds to support) (Table 3). A similar
pattern was seen for receipt and adherence to
psychological treatments, although this did not
reach statistical signiﬁcance for factor 1. Those
who reported disclosure (telling family and/or
Table 1. Characteristics of the study partici-
pants with an ICD-10 depressive episode in the
12 months prior to interview (n=865a), compar-
ing mild and moderate versus severe depressive
episodes
Mild/
moderate Severe p
Female, n (%) 122 (66.0) 498 (74.8) 0.04
Mean age, years (S.D.) 50.7 (13.9) 44.0 (13.6) <0.0001
Mean screen score (S.D.) 6.2 (1.4) 7.5 (1.8) <0.001
Marital status, n (%)
Single 17 (9.1) 108 (16.2) 0.002
Married 135 (72.6) 388 (58.4)
Separated/divorced/
widowed
34 (18.3) 169 (25.4)
Employment, n (%)
Employed 98 (52.7) 333 (50.2) 0.15
Unemployed 4 (2.2) 35 (5.3)
Inactive 84 (45.2) 296 (44.6)
Rented accommodation,
n (%)
49 (26.3) 220 (33.0) 0.06
No car access, n (%) 25 (13.4) 122 (18.0) 0.15
Education, n (%)
A level+ 50 (27.5) 187 (28.4) 0.30
GCSE or equivalent 75 (41.2) 305 (46.3)
No qualiﬁcations 57 (31.3) 167 (25.3)
Financial strain, n (%)
Comfortable/alright 134 (72.8) 423 (63.9) 0.04
Diﬃcult or very diﬃcult 50 (27.2) 239 (36.1)
S.D., Standard deviation.
a Totals do not always add up to 866 because of missing data.
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FIG. 1. Scree plot derived from principal factor analysis of the
Attitudes to Depression and its Treatment (AdepT) questionnaire.
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friends about their depressive episode) had
signiﬁcantly higher scores on factor 2 and lower
scores on factors 1 and 3.
DISCUSSION
One of the most notable ﬁndings from this
research was the subtle range of attitudes about
depression and its outcome that we elicited. This
view was supported by the modest internal
reliability of the 19-item ADepT questionnaire,
and by the results of factor analysis. We ident-
iﬁed three factors within the responses to this
instrument. The ﬁrst factor had high loadings
from items reﬂecting a view of depression as a
permanent, disabling and stigmatizing mental
breakdown from which there was little prospect
of recovery. The second factor reﬂected a more
sympathetic view of depression as a medical
condition that could aﬀect anyone and from
which recovery was possible with support and
help. Finally, a third, bipolar, factor concerned
antidepressant medication, with high scores
indicating a view of these as ineﬀective and ad-
dictive. Further analysis revealed little variation
with depression severity, although among those
with mild and moderate depression there was
some evidence of less concern with concealment
and a more normalizing attitude to recovery.
Despite the relative clarity of interpretation,
we cannot be certain of the direction of these
associations; such attitudes may determine
Table 2. Results of principal factor analysis of responses to the AdepT questionnaire, showing
item loadings on three retained factors after varimax rotation. Items concerning treatment are
shown in bold
Item Factor 1 Factor 2 Factor 3
1. Depression is a sign of weakness 0.61 x0.14 0.20
2. People with depression are more creative and imaginative than others 0.05 x0.01 x0.01
3. People with depression are hard to talk to 0.42 x0.05 0.09
4. People who have experienced depression are understanding and compassionate 0.03 0.30 x0.05
5. People with depression deserve a lot of support from their friends and family x0.01 0.50 x0.05
6. If you have depression, you should be able pull to yourself together 0.36 x0.26 0.31
7. Counselling is an eﬀective way of treating depression 0.002 0.34 x0.20
8. Depressed people are often unstable 0.53 0.02 x0.05
9. Depression is a medical condition, just like any other illness x0.13 0.46 x0.18
10. People with depression are a danger to others 0.46 x0.13 x0.001
11. Depression does not usually get better with treatment 0.25 x0.20 0.36
12. You must be careful not to upset someone who has been
depressed, or they will get ill again
0.42 x0.06 0.15
13. Antidepressants are an eﬀective way of treating depression x0.03 0.16 –0.54
14. People who have suﬀered from depression never recover 0.43 x0.20 0.17
15. Depression is always caused by problems in people’s lives 0.26 0.12 0.27
16. If other people knew I had been depressed, they would think less of me 0.50 0.09 0.10
17. When I have been depressed in the past, I have kept it a secret 0.42 0.07 0.19
18. Anybody can suﬀer from depression x0.15 0.43 x0.02
19. Antidepressants are addictive 0.18 x0.002 0.58
AdepT, Attitudes to depression and its treatment.
Table 3. Unadjusted mean diﬀerence in ADepT factor scores between those who received and
adhered to evidence-based treatments and those who did not, and between those who disclosed their
depressive episode to family and/or friends and those who did not
Factor
Medication, mean
diﬀerence (S.E.) p
Psychological treatment,
mean diﬀerence (S.E.) p
Disclosure, mean
diﬀerence (S.E.) p
1 Permanent, disabling and stigmatizing x0.13 (0.06) 0.02 0.08 (0.10) 0.39 x0.24 (0.07) 0.001
2 Medical condition that responds to support 0.16 (0.04) 0.001 0.22 (0.08) 0.01 0.29 (0.06) <0.001
3 Antidepressants are addictive and ineﬀective x0.51 (0.04) <0.001 x0.27 (0.09) 0.003 x0.12 (0.05) 0.03
AdepT, Attitudes to depression and its treatment ; S.E., standard error.
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concordance with treatments, or experiences
of treatment and support may lead to these
attitudes to depression. These ﬁndings do,
however, stand in contrast to many previous
reports, which have tended to concentrate
almost exclusively on dichotomous views about
the acceptability or otherwise of treatment
(Pyne et al. 2005).
Strengths and weaknesses of the study
The present ﬁndings are based on a very large
sample of individuals with ICD-10 depressive
episodes in the 12 months preceding interview,
the majority of which were of at least moderate
severity. These individuals were recruited from
among consecutive primary care attendees,
and depressive episodes were conﬁrmed using a
validated, standardized clinical interview. The
36 participating practices were recruited from
across England and Wales. This is one of the
largest, most diverse and best validated samples
of this type ever recruited in the UK. By re-
cruiting individuals with a depressive episode at
any time in the preceding 12 months, our sample
was likely to be more representative of all those
with depression than cross-sectional samples
of those with current depression, in terms of
attitudes to this condition and its treatment
(Singleton et al. 2001). Cross-sectional samples
are likely to include substantial numbers of
those with chronic depression as well as those
with episodes of recent onset. Thus, a prevalence
sample will include many who are treatment
resistant (or treatment reluctant), as well as
those who have not yet had the opportunity to
experience treatment.
One weakness of this study was the high rate
of attrition between screening and interview.
Although non-participation may limit the
generalizability of study ﬁndings, it does not
usually aﬀect their validity (Hennekens &
Buring, 1987). Although less than half of those
who were eligible for the second-stage interview
agreed to take part, screening questionnaire
scores did not diﬀer signiﬁcantly between those
who were and were not interviewed. Never-
theless, we cannot exclude the possibility that
those who were interviewed diﬀered in other
ways, including their willingness to receive and
adhere to treatment. Although scores on the
ADepT questionnaire might not be wholly rep-
resentative of those with a history of moderate
or severe depression, it is unlikely that non-
participation at interview would have resulted in
biased estimates of association between atti-
tudinal measures and either treatment receipt/
adherence or disclosure. For this to have
occurred, non-participation would have to have
been associated with both attitudes to depres-
sion and treatment receipt or disclosure.
A further weakness is that the ADepT ques-
tionnaire is in eﬀect a new instrument; although
based on items from other measures, we cannot
be wholly certain of their reliability. We would,
however, argue that the criterion validity of
this questionnaire was evidenced by the patterns
of association between factor scores and
indices of treatment receipt/adherence, and dis-
closure.
Identifying and quantifying the adequacy of
treatment delivery and adherence is extremely
challenging, and despite the proliferation of
diﬀerent ways of measuring adherence, there is
no agreed gold standard (Garber et al. 2004;
DiMatteo & Haskard, 2006). We chose to rely
on patient reports in both instances in the con-
text of a comprehensive, structured face-to-face
interview. We were careful to begin by eliciting
evidence of a depressive episode in the preceding
12 months, and then using this to anchor the
remainder of the interview, which covered
the onset and duration of symptoms, and re-
lated help-seeking. We enumerated all possible
pharmacological and psychological treatments,
and asked about the dose, duration and cir-
cumstances of termination for each. Although
this method was not formally validated, the
approach was thorough and systematic. By re-
cording both the names and doses of diﬀerent
medications, it is unlikely that rates of prescrib-
ing were over-reported. We would also argue
that the pattern of associations with responses
to the ADepT questionnaire provides evidence
of the validity of our treatment receipt and ad-
herence data. While some psychiatrists might
view the treatment criteria as potentially inclu-
sive of subtherapeutic interventions, these were
entirely in keeping with previous research in
community and primary care settings (Wang
et al. 2005). For this reason, we described these
collectively as ‘minimally adequate treatment ’.
The most important point is that these criteria
were operationalized and applied systematically
and without bias to the entire sample.
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Future directions
These ﬁndings highlight the need for GPs to
explore people’s attitudes to depression prior to
considering treatments, and indeed it might be
argued that this should be part of the assessment
of depression. However, it is important to
stress that this study cannot distinguish between
attitudes as the cause or consequence of speciﬁc
treatment experiences. While it might be that
particular views (such as seeing depression as a
medical condition likely to respond to treat-
ment) could enhance treatment receipt and
adherence, it is also possible that the attitudes
elicited were shaped by treatment experiences.
There is now a need for longitudinal research
to explore this further, as well as intervention
studies to evaluate the mediating or modifying
eﬀects of patients’ beliefs and attitudes on
treatment outcomes.
CONCLUSIONS
Even after experiencing a moderate or severe
depressive episode, individuals continue to have
very subtle and often divergent views about
this condition, its outcome, and the most ap-
propriate forms of help. These go far beyond
whether particular treatments are acceptable
or not, and encompass beliefs about the nature
and causes of depression itself. Such beliefs are
likely to have signiﬁcant implications for help
seeking, consultation outcomes and adherence
to treatment.
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